SMARThealth MLTC: Development and feasibility testing of a comprehensive management package for multiple long-term conditions in India and Indonesia
Background
SMARThealth is a digital primary health care ecosystem developed by The George Institute to overcome limitations in chronic disease care, particularly in low resource settings. Designed for use by community healthcare workers (CHWs), it supports the Systematic Medical Appraisal, Referral and Treatment (SMART) of chronic conditions through evidence-based point of care decision support.
People living with multiple long-term conditions (MLTCs) often receive care that is disjointed and focused on individual diseases rather than the person as a whole. This siloed approach leads to suboptimal health outcomes and inefficiencies in the healthcare system.
Current health services are not designed to manage the complex and intersecting needs of individuals with MLTCs. There is a pressing need to develop integrated, person-centred approaches that can deliver coordinated, high-quality care for people with MLTCs in low-resource settings.
Aim
To develop and conduct a pre
GODIF: Goal-directed fluid removal with furosemide in intensive care patients
Background
Each year, more than 170,000 Australians are treated in intensive care units, where nearly all receive intravenous fluids to maintain their blood pressure and circulatory stability. However, when not carefully managed, this treatment can result in fluid overload, a condition linked to multi-organ failure and a higher risk of death. Studies show that for every extra millilitre per kilogram of fluid given, the risk of mortality rises by 2%. Despite the widespread use and potential serious consequences of fluid therapy, there is a major gap in evidence to guide when and how best to remove excess fluid.
Fluid overload remains a complex and often overlooked issue in Australian ICUs, with research indicating that patients frequently maintain a positive fluid balance during the early days of intensive care, which correlates with higher hospital mortality. International findings highlight the global impact of this problem, yet no randomised trials have tested fluid removal strategies in gen
Potassium-enriched salt: Scaling up the use of potassium-enriched salt
BackgroundLeading international scientific organisations and national governments worldwide recognise that reducing population sodium intake is a key priority to prevent and control noncommunicable diseases.Reducing sodium consumption is particularly important for low- and middle-income countries as the burden of excess sodium intake is disproportionately severe due to limited access to health resources and effective treatments. Marginalised and underserved communities also face heightened risks because of dietary, economic, and systemic challenges, exacerbating their health disparities.Despite global efforts to reduce salt intakes, progress has been slow due to a lack of practical interventions.Switching regular salt to potassium-enriched salt is likely to be the most effective solution based on a growing body of evidence:Salt Substitute in India Study (SSiIS) – A randomised controlled trialChina Salt Substitute and Stroke Study (SSaSS)AimTo generate evidence for and scale up the switch to potassium-enrich
Six reasons why: Compelling co-benefits of lowering speed on our streets
Policy & Practice Report
Addressing heart disease and diabetes through use of the WHO PEN interventions in Fiji
Background Fijians experience alarming trend in deaths from heart disease before the age of 70. According to the World Health Organization data from 2017, Fiji ranked 39 out of 183 countries in the world in fatalities from heart disease. Fiji conducted the WHO STEPS survey for surveillance of major NCD risk factors in 2002 and 2011 and found significant increases in risk factors contributing to CVD: high blood pressure, high fasting blood glucose and obesity. Pacific Forum Leaders declaring the situation a “human, social and economic crisis”. The WHO PEN program is a set of low-cost tools to prevent the risk of chronic disease (e.g. lifestyle counselling, monitoring and control of blood pressure and blood glucose, and treatment).
Aims In 2012, the Western Pacific WHO commenced implementation of PEN protocols 1 and 2 for prevention of CVD and diabetes. The overall aim is to provide evidence on 1) implementation fidelity, (2) processes of adoption of the PEN program by healthcare pr
Priorities for the UN High-Level Meeting on Non-Communicable Diseases (NCDs) 2025
Policy & Practice Report
The path forward for Health Star Ratings
Policy & Practice Report
Improving first response to childhood burns in Uganda
Background:Globally, nearly 9 million injuries and ~180,000 deaths occur annually due to burns, with the majority occurring in low-and middle-income countries. Almost two-thirds of burn injuries occur in Africa and South-East Asia. Young children are disproportionally affected with under 5-year-olds in the African region having an incidence of burn deaths of over double the global rate. Burn injuries are particularly problematic in urban slum communities such as Kisenyi, where our recent work revealed an extremely high incidence (32%) of burns in children under the age of 5.Current first aid responses frequently involve home remedies such as applying cooking oil and sugar, eggs and other food materials, commercial creams, toothpaste, soap and traditional medicines including mixtures of urine, mud and cow dung. Yet best practice involves simply cooling the burn with water. Additionally, research shows carers are often reluctant to seek formal medical care – a key factor in poor outcomes for children with bur
Response to call for information on Nutrition Labelling - Health Star Rating and Nutrition Information Panel
Policy & Practice Report
Preparing for the future of the Health Star Rating (HSR) System
Policy & Practice Report
Investing in the prevention of chronic disease to increase productivity in the Australian economy: submission to the Economic Reform Roundtable
Policy & Practice Report
Improving health care outcomes through sex and gender policies in health and medical research
Background There is a long-standing assumption that medicine, and the research underpinning medical interventions, is sex and gender neutral, however there is a growing body of evidence describing sex and gender differences in disease prevention, diagnosis, treatment and health outcomes. Despite this, much research continues to be done without taking sex and gender into account, leading to gaps in the evidence base informing our health care policy and practice
Aims To address gaps in the collection, analysis and reporting of sex and gender in health and medical research in Australia. To build capacity among researchers, scientists and clinicians, and drive change in this area
Method
The project involves three phases: Surveys, interviews, web-based searches; Development and evaluation of policy frameworks and training materials; and Health economic analysis.
Potential Impact Each stakeholder within the health and medical research sector in Australia encourages